These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32682341)

  • 1. Noxa upregulation and 5-gene apoptotic biomarker panel in colorectal cancer.
    Kosmidou V; Vlassi M; Anagiotos K; Raftopoulou S; Kalogerakou E; Skarmalioraki S; Aggeli C; Choreftaki T; Zografos G; Pintzas A
    Eur J Clin Invest; 2021 Jan; 51(1):e13353. PubMed ID: 32682341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer.
    Devetzi M; Kosmidou V; Vlassi M; Perysinakis I; Aggeli C; Choreftaki T; Zografos GN; Pintzas A
    Sci Rep; 2016 Nov; 6():36532. PubMed ID: 27827395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
    Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
    Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of Noxa-mediated apoptosis in Helicobacter pylori-infected gastric epithelial cells.
    Rath S; Das L; Kokate SB; Pratheek BM; Chattopadhyay S; Goswami C; Chattopadhyay R; Crowe SE; Bhattacharyya A
    FASEB J; 2015 Mar; 29(3):796-806. PubMed ID: 25404713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer.
    Xu S; Ma Y; Tong Q; Yang J; Liu J; Wang Y; Li G; Zeng J; Fang S; Li F; Xie X; Zhang J
    Cell Death Dis; 2021 Mar; 12(3):265. PubMed ID: 33712558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells.
    Kabir S; Cidado J; Andersen C; Dick C; Lin PC; Mitros T; Ma H; Baik SH; Belmonte MA; Drew L; Corn JE
    Elife; 2019 Jul; 8():. PubMed ID: 31294695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation.
    Arai S; Varkaris A; Nouri M; Chen S; Xie L; Balk SP
    Elife; 2020 Jun; 9():. PubMed ID: 32484436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
    Chiou JT; Chang LS
    Biochem Pharmacol; 2024 Jun; 224():116242. PubMed ID: 38679209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma.
    Fu D; Pfannenstiel L; Demelash A; Phoon YP; Mayell C; Cabrera C; Liu C; Zhao J; Dermawan J; Patil D; DeVecchio J; Kalady M; Souers AJ; Phillips DC; Li X; Gastman B
    Cell Death Dis; 2022 Jan; 13(1):63. PubMed ID: 35042842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Effects of Treatment of Human Colorectal Cancer Cells with Natural and Classical Chemotherapeutic Drugs: Alterations in the Expression of Apoptosis-related BCL2 Family Members, Including BCL2L12.
    Kontos CK; Avgeris M; Vassilacopoulou D; Ardavanis A; Scorilas A
    Curr Pharm Biotechnol; 2018; 19(13):1064-1075. PubMed ID: 30417787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer.
    Kim SL; Min IS; Park YR; Lee ST; Kim SW
    Int J Oncol; 2018 Dec; 53(6):2789-2799. PubMed ID: 30221676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.
    Jagadish N; Parashar D; Gupta N; Agarwal S; Purohit S; Kumar V; Sharma A; Fatima R; Topno AP; Shaha C; Suri A
    J Exp Clin Cancer Res; 2015 Nov; 34():142. PubMed ID: 26590805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between BCL2 and Mcl1 Single Nucleotide Polymorphisms and Chemotherapy Response in Jordanian Patients with Colorectal Cancer.
    Mhaidat NM; Amawi H; Alzoubi KH
    Curr Pharm Biotechnol; 2021; 22(5):646-653. PubMed ID: 32619164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
    Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
    J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa.
    de Bruijn MT; Raats DA; Hoogwater FJ; van Houdt WJ; Cameron K; Medema JP; Borel Rinkes IH; Kranenburg O
    Br J Cancer; 2010 Apr; 102(8):1254-64. PubMed ID: 20354524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
    Chiou JT; Lee YC; Wang LJ; Chang LS
    Chem Biol Interact; 2022 Jul; 361():109978. PubMed ID: 35561756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells.
    Risberg K; Redalen KR; Sønstevold L; Bjørnetrø T; Sølvernes J; Ree AH
    BMC Cancer; 2016 Jul; 16():531. PubMed ID: 27461218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.
    Park SH; Lee DH; Kim JL; Kim BR; Na YJ; Jo MJ; Jeong YA; Lee SY; Lee SI; Lee YY; Oh SC
    Oncotarget; 2016 Sep; 7(37):59503-59518. PubMed ID: 27517746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
    Yang Z; An Y; Wang N; Dong X; Kang H
    J Cell Physiol; 2020 Oct; 235(10):7449-7464. PubMed ID: 32064615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477.
    Mallick DJ; Soderquist RS; Bates D; Eastman A
    Cell Death Dis; 2019 Feb; 10(3):185. PubMed ID: 30796196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.